Neuralink
PrivateLast Round
Series E
May 27, 2025
Est. Valuation
$9.6B
Total Funding Raised
$1.25B
Company Overview
Neuralink is a neurotechnology company that develops implantable brain-machine interfaces aimed at assisting individuals with paralysis and addressing neurological conditions while potentially enhancing cognitive abilities.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Clinical Trials, Industrial Robotics
Business Model
B2B2C
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuralink Comps
Public and private peers based on sector, stage, and business model.
Neuralink Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | May 27, 2025 | ||||
| Series D | Aug 5, 2023 | ||||
| Series C | Jul 29, 2021 | ||||
| Funding Round | May 10, 2019 | ||||
| Series A | Aug 1, 2017 |
Secondary Market Activity
Bids, offers, and trades by month
| Operation | Date | Price | Size | Share Class | Structure |
|---|---|---|---|---|---|
BID | |||||
BID | |||||
BID | |||||
OFFER |
Key People
Founding team and executive leadership
Neuralink Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Human Capital | Series D, Series E |
| Future Ventures | Series C |
| Time BioVentures | Series C |
| GV | Series C |
| Craft Ventures | Series C, Funding Round |
| CoreNest | Series E |
| Founders Fund | Series C, Series E, Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2026
Blackrock Neurotech was mentioned as one of a few BCI companies to have received Breakthrough Device designation from the FDA to date.
- Apr 9, 2026
Synchron was mentioned as one of a few BCI companies to have received Breakthrough Device designation from the FDA to date.
Neuralink Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neuralink's valuation, stock price, and market status.
